CCL2 and atherosclerosis: In addition, GDF-15 was able to inhibit the oxLDL-induced inflammatory response (including the downregulation of IL-6, IL-8, MCP-1, and MMP-9 in oxLDL-treated macrophages), which promotes the initiation and development of atherosclerosis.